Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
RATIONALE: Drugs used in chemotherapy and hormone therapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of fludarabine plus octreotide in treating patients who have relapsed low-grade non-Hodgkin\'s lymphoma.
Epistemonikos ID: 5aa8c0c1a399a136a6caf73164bae33fa68606a4
First added on: May 03, 2024